3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors
申请人:Aventis Pharmaceuticals Inc.
公开号:EP1834947A2
公开(公告)日:2007-09-19
This invention discloses and claims a new class of indole derivatives for use in treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and diseases associated with bacterial, rhinovirus or respiratory syncytial virus (RSV) infections. It has now been found that the compounds of this invention are capable of modulating T helper (Th) cells, Thl/Th2, and thereby capable of inhibiting the transcription of interleukin-4 (IL-4) message, IL-4 release or IL-4 production.
本发明公开了一类新的吲哚衍生物,用于治疗过敏、哮喘、鼻炎、皮炎、B 细胞淋巴瘤、肿瘤以及与细菌、鼻病毒或呼吸道合胞病毒(RSV)感染有关的疾病。现已发现,本发明的化合物能够调节 T 辅助(Th)细胞 Thl/Th2,从而能够抑制白细胞介素-4(IL-4)信息的转录、IL-4 的释放或 IL-4 的产生。